<h1>Series 3: A tricyclic antifungal drug devlopment project</h1>
45 lines (45 loc) · 5.51 KB
Molecule Name	SMILES	Molecular weight (g/mol)	Batch Name	External Identifier	Excess_material_(mg)	Excess_material_Stor
NEU-0007393	CC(C)NCCN1C2=CC=C(NC(C)=O)C=C2C2=C1C=CC(NC(C)=O)=C2	366.465	AA-001	PG-01-136	5	PG-BOX-01
NEU-0007207	CC(C)NCCN1C2=CC=C(N3CC4(COC4)C3)C=C2C2=C1C=CC(N1CC3(COC3)C1)=C2	446.595	AA-001	PG-01-25	5	Pradip Gadekar box 1
NEU-0005766	CC(=O)C1=CC2=C(NC3=CC=C(C(C)=O)C=C23)C=C1	251.285	AA-001, AA-002	MR-1-050-02	5	Mitch's Box
NEU-0005765	CC(=O)C1=CC2=C(C=C1)N(CCN1CCNCC1)C1=CC=C(C(C)=O)C=C21	363.461	AA-001	MR-1-043-01	5	Mitch's Box
NEU-0005328	C[C@@H]1CNCCN1C(=O)C1=CC=C(C2=CC(N3CCOCC3)=CC=C2)C=C1N	380.492	AA-001	HJ-1-123-3	5	Hitesh Box-1
NEU-0005767	CC(=O)C1=CC2=C(C=C1)N(CCNC1CC1)C1=CC=C(C(C)=O)C=C21	334.419	AA-001	MR-1-057-01	6	Mitch's Box
NEU-0006059	C[C@H]1COCCN1CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	378.472	AA-001	MR-1-137-01	7	Mitch's Box
NEU-0005771	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCCCCC1)C1=CC=C(C(C)=O)C=C21	390.527	AA-001	MR-1-061-01	7	Mitch's Box
NEU-0005770	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCC1)C1=CC=C(C(C)=O)C=C21	348.446	AA-001	MR-1-060-01	7	Mitch's Box
NEU-0005768	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCCCC1)C1=CC=C(C(C)=O)C=C21	376.5	AA-001	MR-1-058-01	7	Mitch's Box
NEU-0006058	CC(=O)C1=CC2=C(C=C1)N(CCN1CCCOCC1)C1=CC=C(C(C)=O)C=C21	378.472	AA-001	MR-1-131-01	8	Mitch's Box
NEU-0005769	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCCC1)C1=CC=C(C(C)=O)C=C21	362.473	AA-001	MR-1-059-01	8	Mitch's Box
NEU-0007368	CC(C)NCCN1C2=CC=C(N)C=C2C2=C1C=CC(N)=C2	282.391	AA-001	PG-01-62	10	PG-BOX-01
NEU-0007251	CC(=O)C1=CC2=C(C=C1)N(CCN1CC3(COC3)C1)C1=CC=C(C(C)=O)C=C21	376.456	AA-001	PG-01-47	10	PG- Box -1
NEU-0007250	CC(C)NCCN1C2=CC=C(NC(=O)OC(C)(C)C)C=C2C2=C1C=CC(NC(=O)OC(C)(C)C)=C2	482.625	AA-001	PG-01-35-1	10	PG-BOX-01
NEU-0007249	CC(C)NCCN1C2=CC=C(N3CC4(CN(C(=O)OC(C)(C)C)C4)C3)C=C2C2=C1C=CC(N1CC3(CN(C(=O)OC(C)(C)C)C3)C1)=C2	644.861	AA-001	PG-01-27-1	10	PG-BOX-01
NEU-0006878	CN(C)CCNCCN1C2=CC=C(OC(F)(F)F)C=C2C2=C1C=CC(OC(F)(F)F)=C2	449.395	AA-001	GN-01-179-01	10	Naresh final compounds box 2
NEU-0006877	CC(C)NCCN1C2=CC=C(OC(F)(F)F)C=C2C2=C1C=CC(OC(F)(F)F)=C2	420.353	AA-001	GN-01-178-02	10	Naresh final compounds box 2
NEU-0006794	CC(C)NCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC=C2	294.398	AA-001	GN-01-146-02	10	
NEU-0006038	CC1CN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)C1	348.446	AA-001	MR-1-111-01	10	Mitch's Box
NEU-0006037	CC(=O)C1=CC2=C(C=C1)N(CCN1CC(F)(F)C1)C1=CC=C(C(C)=O)C=C21	370.399	AA-001	MR-1-110-01	10	Mitch's Box
NEU-0005326	CN1CCN(C2=NC=C(C3=CC4=C(C=C3)C(NCC3CCOCC3)=CC=N4)C=N2)CC1	418.545	AA-001	KB2-342-3-1	10	kb_box1
NEU-0006070	C[C@@H]1COCCN1CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	378.472	AA-001	MR-1-139-01	14	Mitch's Box
NEU-0006469	CCOC(=O)C1=CC2=C(C=C1)N(CCNC(C)C)C1=CC=C(C(=O)OCC)C=C21	396.487	AA-001	GN-01-54-01	15	
NEU-0006040	CN(C)C1CN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)C1	377.488	AA-001	MR-1-123-01	15	Mitch's Box
NEU-0005993	CC(=O)C1=CC2=C(C=C1)N(CCCN1CCCC1)C1=CC=C(C(C)=O)C=C21	362.473	AA-001	MR-1-091-01	15	349
NEU-0006467	CN(C)C1CCC(NCCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)CC1	419.569	AA-001	MC-01-003-10	19.7	Curaxins Box
NEU-0006497	CC(C)NCCN1C2=CC=C(C(F)(F)F)C=C2C2=C1C=CC(C(F)(F)F)=C2	388.355	AA-001	GN-01-65-01	20	
NEU-0005879	CCCNCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	336.435	AA-001, AQ-001	BS-3-029-06	20	Baljinder box-3
NEU-0006468	CC(=O)C1=CC=C2N(CCNCCN3CCCC3)C3=C(C=C(C(=O)C)C=C3)C2=C1	391.515	AA-001	MC-01-004-09	21.5	Curaxins Box
NEU-0006060	CC(=O)C1=CC=C2N(CCN3CCCCC3)C3=CC=C(C(C)=O)C=C3C2=C1	362.473	AA-001	CL-1-007	21.6	Curaxin Sample Box
NEU-0005882	CC(=O)C1=CC2=C(C=C1)N(CCN1C=CN=C1)C1=CC=C(C(C)=O)C=C21	345.402	AA-001	EB-1-027	29.7	E. Burchfield_Box1
NEU-0006071	CC(C)OCCN1C2=C(C=C(C(C)=O)C=C2)C2=C1C=CC(C(C)=O)=C2	337.419	AA-001	BS-3-042-02	30	Baljinder Box-4
NEU-0006452	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCOCC1)C1=CC=C(C(C)=O)C=C21	378.472	AA-001	MC-01-002-03	35	Curaxin box
NEU-0006417	CN(C)CCN(C)CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	379.504	AA-001	BG3-029-3	48.9	Carbazole Final Compound Box
NEU-0006418	CC(C)N(C)CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	350.462	AA-001	BG3-031-3	86.9	Carbazole Final Compound Box
NEU-0005161	CC(C)NCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	336.435	AA-001, AA-002, AA-003, AQ-001	KMW-curaxin-15, BS-3-009-01, BS-3-045-01, Clev-CLB0137	200	Curaxin box
NEU-0006036	CN(C)CCNCCN1C2=C(C=C(C(C)=O)C=C2)C2=C1C=CC(C(C)=O)=C2	365.477	AA-002, AQ-001, AQ-002, AA-003, AA-001	BG3-027-3, GN-01-48-02, GN-01-168-07, PG-01-153, CL-1-004	150, 3, 30, 33.5	Naresh final compounds box, PG-BOX-01, Curaxin Sample Box in 349 EG
NEU-0005315	CN1CCN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)CC1	377.488	AA-002, AA-001	MR-1-118-01, MR-1-017-01	5	MR-Box1
NEU-0006768	CN(C)CCNCCN1C2=CC=C(C(F)(F)F)C=C2C2=C1C=CC(C(F)(F)F)=C2	417.397	AA-002, AQ-001, AA-001	PG-01-92, PG-01-109, GN-01-127-07	100, 20, 10	PG-BOX-01, PG-BOX-01
NEU-0005313	CC(=O)C1=CC2=C(C=C1)N(CCN1CCC1)C1=CC=C(C(C)=O)C=C21	334.419	AA-002, AA-003, AA-001	BG3-022-04, GN-01-129-01, MR-1-030-01	190, 20	Curaxin Final compounds box
NEU-0005137	CN(C)CCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	336.435	AA-002, AA-001, AA-003	KMW-curaxin-20, JA-1-42	5.7	J. Armand box 1, J. Armand box 1, J. Armand box 1
NEU-0005310	CN1CCCN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)CC1	391.515	AA-002, AA-003, AA-004, AA-001	BG3-015-3, BG3-028-4, GN-01-97-07, MR-1-018-01	7, 132.6, 50	Curaxin Final compounds box, Curaxin Final Compound Box
NEU-0006909	CC(=O)C1=CC2=C(C=C1)N(CCN1CCN(C3COC3)CC1)C1=CC=C(C(C)=O)C=C2145 lines (45 loc) · 5.51 KB
Molecule Name	SMILES	Molecular weight (g/mol)	Batch Name	External Identifier	Excess_material_(mg)	Excess_material_Stor
NEU-0007393	CC(C)NCCN1C2=CC=C(NC(C)=O)C=C2C2=C1C=CC(NC(C)=O)=C2	366.465	AA-001	PG-01-136	5	PG-BOX-01
NEU-0007207	CC(C)NCCN1C2=CC=C(N3CC4(COC4)C3)C=C2C2=C1C=CC(N1CC3(COC3)C1)=C2	446.595	AA-001	PG-01-25	5	Pradip Gadekar box 1
NEU-0005766	CC(=O)C1=CC2=C(NC3=CC=C(C(C)=O)C=C23)C=C1	251.285	AA-001, AA-002	MR-1-050-02	5	Mitch's Box
NEU-0005765	CC(=O)C1=CC2=C(C=C1)N(CCN1CCNCC1)C1=CC=C(C(C)=O)C=C21	363.461	AA-001	MR-1-043-01	5	Mitch's Box
NEU-0005328	C[C@@H]1CNCCN1C(=O)C1=CC=C(C2=CC(N3CCOCC3)=CC=C2)C=C1N	380.492	AA-001	HJ-1-123-3	5	Hitesh Box-1
NEU-0005767	CC(=O)C1=CC2=C(C=C1)N(CCNC1CC1)C1=CC=C(C(C)=O)C=C21	334.419	AA-001	MR-1-057-01	6	Mitch's Box
NEU-0006059	C[C@H]1COCCN1CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	378.472	AA-001	MR-1-137-01	7	Mitch's Box
NEU-0005771	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCCCCC1)C1=CC=C(C(C)=O)C=C21	390.527	AA-001	MR-1-061-01	7	Mitch's Box
NEU-0005770	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCC1)C1=CC=C(C(C)=O)C=C21	348.446	AA-001	MR-1-060-01	7	Mitch's Box
NEU-0005768	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCCCC1)C1=CC=C(C(C)=O)C=C21	376.5	AA-001	MR-1-058-01	7	Mitch's Box
NEU-0006058	CC(=O)C1=CC2=C(C=C1)N(CCN1CCCOCC1)C1=CC=C(C(C)=O)C=C21	378.472	AA-001	MR-1-131-01	8	Mitch's Box
NEU-0005769	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCCC1)C1=CC=C(C(C)=O)C=C21	362.473	AA-001	MR-1-059-01	8	Mitch's Box
NEU-0007368	CC(C)NCCN1C2=CC=C(N)C=C2C2=C1C=CC(N)=C2	282.391	AA-001	PG-01-62	10	PG-BOX-01
NEU-0007251	CC(=O)C1=CC2=C(C=C1)N(CCN1CC3(COC3)C1)C1=CC=C(C(C)=O)C=C21	376.456	AA-001	PG-01-47	10	PG- Box -1
NEU-0007250	CC(C)NCCN1C2=CC=C(NC(=O)OC(C)(C)C)C=C2C2=C1C=CC(NC(=O)OC(C)(C)C)=C2	482.625	AA-001	PG-01-35-1	10	PG-BOX-01
NEU-0007249	CC(C)NCCN1C2=CC=C(N3CC4(CN(C(=O)OC(C)(C)C)C4)C3)C=C2C2=C1C=CC(N1CC3(CN(C(=O)OC(C)(C)C)C3)C1)=C2	644.861	AA-001	PG-01-27-1	10	PG-BOX-01
NEU-0006878	CN(C)CCNCCN1C2=CC=C(OC(F)(F)F)C=C2C2=C1C=CC(OC(F)(F)F)=C2	449.395	AA-001	GN-01-179-01	10	Naresh final compounds box 2
NEU-0006877	CC(C)NCCN1C2=CC=C(OC(F)(F)F)C=C2C2=C1C=CC(OC(F)(F)F)=C2	420.353	AA-001	GN-01-178-02	10	Naresh final compounds box 2
NEU-0006794	CC(C)NCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC=C2	294.398	AA-001	GN-01-146-02	10	
NEU-0006038	CC1CN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)C1	348.446	AA-001	MR-1-111-01	10	Mitch's Box
NEU-0006037	CC(=O)C1=CC2=C(C=C1)N(CCN1CC(F)(F)C1)C1=CC=C(C(C)=O)C=C21	370.399	AA-001	MR-1-110-01	10	Mitch's Box
NEU-0005326	CN1CCN(C2=NC=C(C3=CC4=C(C=C3)C(NCC3CCOCC3)=CC=N4)C=N2)CC1	418.545	AA-001	KB2-342-3-1	10	kb_box1
NEU-0006070	C[C@@H]1COCCN1CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	378.472	AA-001	MR-1-139-01	14	Mitch's Box
NEU-0006469	CCOC(=O)C1=CC2=C(C=C1)N(CCNC(C)C)C1=CC=C(C(=O)OCC)C=C21	396.487	AA-001	GN-01-54-01	15	
NEU-0006040	CN(C)C1CN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)C1	377.488	AA-001	MR-1-123-01	15	Mitch's Box
NEU-0005993	CC(=O)C1=CC2=C(C=C1)N(CCCN1CCCC1)C1=CC=C(C(C)=O)C=C21	362.473	AA-001	MR-1-091-01	15	349
NEU-0006467	CN(C)C1CCC(NCCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)CC1	419.569	AA-001	MC-01-003-10	19.7	Curaxins Box
NEU-0006497	CC(C)NCCN1C2=CC=C(C(F)(F)F)C=C2C2=C1C=CC(C(F)(F)F)=C2	388.355	AA-001	GN-01-65-01	20	
NEU-0005879	CCCNCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	336.435	AA-001, AQ-001	BS-3-029-06	20	Baljinder box-3
NEU-0006468	CC(=O)C1=CC=C2N(CCNCCN3CCCC3)C3=C(C=C(C(=O)C)C=C3)C2=C1	391.515	AA-001	MC-01-004-09	21.5	Curaxins Box
NEU-0006060	CC(=O)C1=CC=C2N(CCN3CCCCC3)C3=CC=C(C(C)=O)C=C3C2=C1	362.473	AA-001	CL-1-007	21.6	Curaxin Sample Box
NEU-0005882	CC(=O)C1=CC2=C(C=C1)N(CCN1C=CN=C1)C1=CC=C(C(C)=O)C=C21	345.402	AA-001	EB-1-027	29.7	E. Burchfield_Box1
NEU-0006071	CC(C)OCCN1C2=C(C=C(C(C)=O)C=C2)C2=C1C=CC(C(C)=O)=C2	337.419	AA-001	BS-3-042-02	30	Baljinder Box-4
NEU-0006452	CC(=O)C1=CC2=C(C=C1)N(CCNC1CCOCC1)C1=CC=C(C(C)=O)C=C21	378.472	AA-001	MC-01-002-03	35	Curaxin box
NEU-0006417	CN(C)CCN(C)CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	379.504	AA-001	BG3-029-3	48.9	Carbazole Final Compound Box
NEU-0006418	CC(C)N(C)CCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	350.462	AA-001	BG3-031-3	86.9	Carbazole Final Compound Box
NEU-0005161	CC(C)NCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	336.435	AA-001, AA-002, AA-003, AQ-001	KMW-curaxin-15, BS-3-009-01, BS-3-045-01, Clev-CLB0137	200	Curaxin box
NEU-0006036	CN(C)CCNCCN1C2=C(C=C(C(C)=O)C=C2)C2=C1C=CC(C(C)=O)=C2	365.477	AA-002, AQ-001, AQ-002, AA-003, AA-001	BG3-027-3, GN-01-48-02, GN-01-168-07, PG-01-153, CL-1-004	150, 3, 30, 33.5	Naresh final compounds box, PG-BOX-01, Curaxin Sample Box in 349 EG
NEU-0005315	CN1CCN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)CC1	377.488	AA-002, AA-001	MR-1-118-01, MR-1-017-01	5	MR-Box1
NEU-0006768	CN(C)CCNCCN1C2=CC=C(C(F)(F)F)C=C2C2=C1C=CC(C(F)(F)F)=C2	417.397	AA-002, AQ-001, AA-001	PG-01-92, PG-01-109, GN-01-127-07	100, 20, 10	PG-BOX-01, PG-BOX-01
NEU-0005313	CC(=O)C1=CC2=C(C=C1)N(CCN1CCC1)C1=CC=C(C(C)=O)C=C21	334.419	AA-002, AA-003, AA-001	BG3-022-04, GN-01-129-01, MR-1-030-01	190, 20	Curaxin Final compounds box
NEU-0005137	CN(C)CCCN1C2=CC=C(C(C)=O)C=C2C2=C1C=CC(C(C)=O)=C2	336.435	AA-002, AA-001, AA-003	KMW-curaxin-20, JA-1-42	5.7	J. Armand box 1, J. Armand box 1, J. Armand box 1
NEU-0005310	CN1CCCN(CCN2C3=CC=C(C(C)=O)C=C3C3=C2C=CC(C(C)=O)=C3)CC1	391.515	AA-002, AA-003, AA-004, AA-001	BG3-015-3, BG3-028-4, GN-01-97-07, MR-1-018-01	7, 132.6, 50	Curaxin Final compounds box, Curaxin Final Compound Box
NEU-0006909	CC(=O)C1=CC2=C(C=C1)N(CCN1CCN(C3COC3)CC1)C1=CC=C(C(C)=O)C=C21
Advantages:
* Phenothiazines show a large spectrum of activity against both fungi and amoeba (including those that cause some NTD's) 
* Extremely low cost and straightforward to produce (only 2 or 3 steps from common materials) (1 kilo of phenothiazine is less than 100 usd from SA)
* Suspected multiple mechanisms of action including calmodulin and lipid synthesis disruption makes resistance unlikely ( https://pubs.acs.org/doi/10.1021/acsinfecdis.7b00157 and https://academic.oup.com/mmy/article/53/8/890/982579 and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815111/ )
* Lipophilic to penetrate into fungal grain 
* Long lasting in vivo (30h t½ for chlorpromazine  and ~10h t½ for trifluoperazine) 
* Phenothiazine drugs has been used in clinical antimicrobial experiments a handful of times: (E.G https://doi.org/10.1016/S0140-6736(83)91769-5 and https://doi.org/10.1086/379020 )

Disadvantages:
* Some tricyclic drugs may cause a tetracycline-like photosensitivity in vivo (We will need to research this more)
* Water solubility is not great
* Agranulocytosis is rare side effect reported from long term use from some but not all drugs in this class (We will need to research this more)
* Parent drugs are neurological ones (the exception being the Curaxin-NEU tricyclics)
with some rather unpleasant side-effects 
<br>
<br>
<br>
<br>
<img src ="https://upload.wikimedia.org/wikipedia/commons/8/81/Fenethazine.svg"> </img>
<br>
